The MAMMAL Drug-Target Interaction API, part of the free Cure Cancer With AI public API, offers a powerful solution for predicting drug-target binding affinities. Specifically, it allows developers and researchers to estimate how strongly a given compound binds to a specific protein target, providing invaluable insights during the early stages of drug discovery. By making this predictive capability accessible via API, it eliminates the need for complex local model setups, enabling quicker iterations and decision-making in the research process.

Why This Endpoint Matters

Understanding the binding affinity between drugs and their target proteins is a critical component of drug discovery. The ability to predict this interaction can streamline the identification of promising drug candidates, allowing researchers to prioritize compounds that are more likely to succeed in further development stages. The MAMMAL model, developed by IBM, leverages advanced machine learning techniques to provide accurate predictions of binding affinities expressed as pKd values.

With this API, researchers can:

• Rapidly assess a large library of compounds against specific targets.
• Triage potential hits before conducting more resource-intensive assays.
• Incorporate binding-affinity signals into their discovery pipelines to enhance their predictive analytics.

How to Use It

The MAMMAL Drug-Target Interaction API uses the POST method and is accessible at the following path:

POST https://curecancerwithai.com/api/v1/mammal/dti

To make a successful request, you need to provide a JSON body containing the following key parameters:

• target_seq: The amino acid sequence of the target protein.
• drug_seq: The drug representation in SMILES format.
• norm_y_mean (optional): Override for normalization mean.
• norm_y_std (optional): Override for normalization standard deviation.

The API will return a JSON response structured as follows:

{
    "data": {
        "pKd": 
    }
}

Here's a practical example of how to call this endpoint using curl:

curl -X POST https://curecancerwithai.com/api/v1/mammal/dti \
-H "Authorization: Bearer ccw_live_YOUR_KEY" \
-H "Content-Type: application/json" \
-d '{
    "target_seq": "MALWMRLLPLLALLALWGPDPAAAFVN",
    "drug_seq": "CC(=O)OC1=CC=CC=C1C(=C(C)C=C(C)C)C(C)=C1",
    "norm_y_mean": 0.0,
    "norm_y_std": 1.0
}'

In this example, replace YOUR_KEY with your actual API key obtained from /api-keys.

What You Can Build

With the MAMMAL Drug-Target Interaction API, the possibilities are vast. Here are a few concrete use cases:

• Compound Library Ranking: Researchers can rank a library of drug candidates against a particular target protein to identify the most promising candidates for further testing.
• Hit Triage: By using the predicted binding affinities, teams can prioritize which hits to move forward with in their experimental validation pipeline, saving time and resources.
• Integration into Discovery Pipelines: The binding-affinity predictions can be integrated into broader drug discovery workflows, enhancing predictive models and analytic frameworks with valuable data signals.

Get Started for Free

The MAMMAL Drug-Target Interaction API is completely free to use. To get started, create your own API key at /api-keys. You’ll also find comprehensive documentation, including parameters and code samples, at /developers. Remember, the free tier allows for up to 100 requests per hour, making it an excellent resource for researchers and developers alike.

As a reminder, while this API provides predictive insights into drug-target interactions, it does not offer medical advice, diagnoses, or guarantees of outcomes. The data and model predictions serve as informational or research signals, and should be used accordingly in the context of drug discovery.

Conclusion

The MAMMAL Drug-Target Interaction API is a significant tool for anyone involved in oncology research or drug development. By providing a straightforward method to predict binding affinities, it empowers researchers to make informed decisions more swiftly and effectively. Start leveraging this capability today and contribute to the exciting field of cancer research!

To dive deeper into practical AI-for-cancer-research updates, explore our latest blog posts, learn more about our mission, and see how you can support ongoing work on our donations page.